A28 Therapeutics, Inc. — Form D

A28 Therapeutics, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-14. The offering totals $1.9M, of which $1.9M was reported sold. Industry: Other Technology.

Offering

• Filed: 2025-01-14
• Form: D
• Accession: 0002051843-25-000001
• Industry: Other Technology
• Exemptions: 06b
• Total offering: $1.9M
• Amount sold: $1.9M
• Investors: 26
• Date of first sale: 2022-02-01
• Revenue range: Decline to Disclose
• SEC file number: 021-535069

Issuer

• Name: A28 Therapeutics, Inc.
• CIK: 0002051843
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 7660 FAY AVENUE H829, LA JOLLA, CA, 92037
• Phone: (713) 252-2619

Officers, directors & promoters (3)

More

• CIK 2051843 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search